Darmstadt, Germany

Ingeborg Lues


Average Co-Inventor Count = 5.6

ph-index = 10

Forward Citations = 400(Granted Patents)


Company Filing History:


Years Active: 1990-2000

Loading Chart...
25 patents (USPTO):Explore Patents

Title: Ingeborg Lues: A Pioneer in Pharmaceutical Innovations

Introduction

Ingeborg Lues, based in Darmstadt, Germany, is a prominent inventor recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 25 patents, her work has greatly influenced the treatment of various health conditions, showcasing her innovative approach to drug development.

Latest Patents

Among her most recent patents are advancements in imidazopyridines. These patents cover imidazopyridine derivatives and pharmacologically acceptable salts that possess antagonistic properties towards angiotensin II. Such innovations are vital in the treatment of hypertension, aldosteronism, and cardiac insufficiency, highlighting her commitment to addressing critical health challenges.

Career Highlights

Ingeborg has worked with leading pharmaceutical companies, including Merck Patent GmbH and Merck Patent Gesellschaft. Her professional journey in these organizations has allowed her to leverage her expertise and further advance her innovative work in drug development.

Collaborations

Throughout her career, Ingeborg has collaborated with esteemed professionals in the field, including Klaus-Otto Minck and Norbert Beier. These partnerships have fostered a rich environment of shared knowledge and innovation, contributing to her success as a leading inventor.

Conclusion

Ingeborg Lues stands out as a key figure in pharmaceutical innovations. Her 25 patents, particularly in imidazopyridines, underscore her impact on treating serious health issues. Through her collaborations and work at major pharmaceutical companies, she continues to push the boundaries of what is possible in medical treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…